Loading

Clinical Features of Benign Tumors of the External Auditory Canal According to Pathology

Research Article | Open Access | Volume 4 | Issue 3

  • 1. Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, South Korea
+ Show More - Show Less
Corresponding Authors
Jae-Jun Song, Department of Otorhinolaryngology – Head and Neck Surgery, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul, 152-703, South Korea, Tel: 82-2-2626-3191
ABSTRACT

Background and Objectives: Benign tumors of the external auditory canal (EAC) are rare among head and neck tumors. The aim of this study was to analyze the clinical features of patients who underwent surgery for an EAC mass confirmed as a benign lesion. Methods: This retrospective study involved 53 patients with external auditory tumors who received surgical treatment at Korea University, Guro Hospital. Medical records and evaluations over a 10-year period were examined for clinical characteristics and pathologic diagnoses. Results: The most common pathologic diagnoses were nevus (40%), osteoma (13%), and cholesteatoma (13%). Among the five pathologic subgroups based on the origin organ of the tumor, the most prevalent pathologic subgroup was the skin lesion (47%), followed by the epithelial lesion (26%), and the bony lesion (13%). No significant differences were found in recurrence rate, recurrence duration, sex, or affected side between pathologic diagnoses. The overall recurrence rate after excision was 11% and higher in patients with fibro epithelial polyp, intra epidermal pilarepithelioma, and chronic inflammation. Culture of otorrhea identified pathogens in half of patients with recurrence, and the recurrence rate was considerably higher (50%) in cases confirmed to be infected by microorganism. Conclusion: Our results indicated that nevus was the most common pathologic diagnoses. The overall recurrence rate was 11%. Benign external auditory canal lesions that originate from the epithelium and bony canal should be observed closely in the postoperative follow-up period. Furthermore, treatment of infection is thought to be important for preventing recurrence.

KEYWORDS

• External auditory canal

• Benign tumor

• Surgical excision

• Recurrence

• Infection

CITATION

Kim JR, Im H, Chae SW, Song JJ (2017) Clinical Features of Benign Tumors of the External Auditory Canal According to Pathology. Ann Otolaryngol Rhinol 4(3): 1169.

ABBREVIATIONS

EAC: External Auditory Canal; MSSA: Methicillin-sensitive Staphylococcus aureus

INTRODUCTION

Benign tumors of the external auditory canal (EAC) are uncommon among head and neck tumors. The EAC begins at the opening of the cup-shaped portion (concha) of the ear, and extends downward to the tympanic membrane. The adult EAC measures 2-3cm in length. The EAC is covered with keratinizing stratified squamous epithelium. The skin over the lateral portion is thicker and contains a subcutaneous layer, hair follicles, sebaceous glands, and wax-secreting ceruminous glands. These skin appendages are absent in the medial two thirds of EAC, where the bony wall is closely adherent to the underlying periosteum [1]. Chronic irritation and inflammation have been considered as causative factors in EAC tumor; however, conclusive evidence of this is lacking [2]. Symptoms are rare but can include conductive hearing loss, otalgia, otorrhea, vertigo, and tinnitus. In previous studies, osteomas were the most commonly found pathologic type in EAC [1,3]. Spielmann et al. reported a 10- year case series of 48 surgically resected EAC masses, including malignant tumors, benign tumors, infective lesions, and epithelial abnormalities. In their study population, bony lesions were the most frequently encountered diagnosis of EAC benign tumors [1]. Wiatr et al. also retrospectively investigated 26 benign EAC tumor cases, and osteoma was the most common pathologic diagnosis [3]. However, there are no concrete data supporting this conventional idea, especially in Asian countries. Furthermore, the prevalence and clinical aspects of various pathological benign tumors arising from the EAC have not yet been investigated with sufficient sample size. The purpose of this study was to describe the correlation of pathologic diagnoses with clinical features in surgically removed benign tumors of the EAC.

MATERIALS AND METHODS

From 2003 to 2014, a retrospective, single-center study of EAC lesions was performed using the medical records of patients who had received surgical treatment for EAC tumors at Department of Otorhinolaryngology-Head and Neck Surgery, Korea University Guro Hospital. A total of 53 patients (26 male and 27 female) were included in the present study. All study protocols were approved by the Institutional Review Board of Korea University Guro Hospital (KUGH15144-001). EAC masses were identified with rigid otoendoscopy, and discovered lesions were surgically excised under and general anesthesia in an operating room. Medical records were reviewed for patients’ age, sex, affected side, pathologic diagnosis, operation records, concurrent infection, and recurrence. Patients were classified into one of five categories according to tumor origin (bony, epithelial, skin, inflammatory and other benign lesions). The epithelial lesion means the diseases in the most superficial layer of skin, stratified squamous epithelium. And skin lesion was defined as the lesions which arise in the dermis and skin appendages excluding epithelium. Statistical analyses were performed using the Statistical Package of the Social Sciences (SPSS, version 21). Results related to patient age are expressed as means (standard eviations, SDs).

RESULTS AND DISCUSSION

Patient characteristics

From 2003 to 2014, a total of 53 patients were diagnosed with EAC tumor under otoendoscopy; all patients underwent excision. Baseline characteristics are shown in Table (1).

Table 1: Characteristics of patients with benign EAC tumors.

Pathologic diagnosis N Incidence (%) Recurrence (n [%]) Recurrence duration (months) Infection (n)
Osteoma 7 13 2(29) 45 0
Chronic inflammation 6 11 1(17) 1 2
Epidermal cyst 5 9 1(20) 1 1
Cholesteatoma 7 13 0   1
Fibroepithelial polyp 1 2 1(100) 1 1
Intraepidermalpilarepithelioma 1 2 1(100) 6 0
  14 26 3(21)   3
Skin lesion          
Nevus 21 40 0   1
Fibrofolliculoma 1 2 0   0
Pilomatricoma 1 2 0   0
Apocrine mixed tumor 1 2 0   0
Apocrine metaplasia of eccrine gland 1 2 0   0
  25 47 0   1
Branchial cleft anomaly 1   0   0
Total 53   6(11) 16.5 6(11%)
Abbreviations: EAC: External Auditory Canal

There were 26 male and 27 female patients, with an average age of 37.0 ± 19.2 years. The right side was affected in 26 patients, and the left in 27 (Table 1). Patients with small EAC tumors had no symptom in many cases, however, patients with large EAC tumors complained of earfulness. In the case of inflammation, otalgia or otorrhea was frequently observed.

In 47 cases, tumors were simply excised via an endaural approach. In 4 patients, canaloplasty was performed with excision; 2 of these also underwent tympanoplasty. In one case, pathologically confirmed as a branchial cleft anomaly, a postauricular approach was used because of the large size of the mass (3×3cm). Statistical analysis revealed no significant differences in age, sex, affected side, recurrence rate, and recurrence duration between the pathologic diagnoses (P > 0.5).

Incidence

In this case series, nevus was the most common pathologic diagnosis. There were 21 patients diagnosed with nevus (40%), followed by osteoma (7 patients, 13%), EAC cholesteatoma (7 patients, 13%), chronic inflammation (6 patients, 11%), epidermal cyst (5 patients, 9%), and others. Among the 21 nevus patients, there were 19 intradermal (90%), 1 compound (5%), and 1 junctional (sebaceous) pathologic types. The most prevalent pathologic subgroup was the skin lesion (25 patients, 47%), followed by the epithelial lesion (14 patients, 26%), and the bony lesion (7 patients, 13%) (Table 1).

Recurrence

During the postoperative follow-up period, recurrent lesions were identified under otoendoscopic evaluation in 6 patients (6 of 53, 11%). The mean follow-up period was 18.4 months. The recurrence rate was 28% (2 of 7) in patients with osteoma, 20% (1 of 5) in those with epidermal cyst, and 17% (1 of 6) in those with chronic inflammation. All patients who were diagnosed with fibro epithelial polyp or intra epidermal pilar epithelioma experienced relapse and underwent re-excision. In one fibro epithleial polyp patient, the tumor recurred twice, necessitating a second revision surgery.

Among the pathologic subgroups, the recurrence rate was highest in the bony lesion group (29%) followed by the epithelial lesion group (21%) and the inflammatory lesion group (17%). In the skin lesion group, no patients experienced recurrence after excision. The average duration of recurrence was 16.5 months, and it was the longest in patients with osteoma (45 months). No patients experienced malignant transformation during the follow-up period.

Infection

We performed bacterial culture of otorrhea preoperatively. Pathogens were confirmed in 6 patients (11%); among these, 3 (50%) had Pseudomonas aeruginosa, and 3 (50%) had methicillin-sensitive Staphylococcus aureus (MSSA). Half of these patients (3 of 6) had re-excision. Three of six recurrent cases also had confirmed pathogens (Table 2).

Table 2: Characteristics of patients with recurrence of benign EAC tumor.

Case Pathologic diagnosis Classification Duration (months) Infection (pathogen) Age (years) Sex Direction
1 Osteoma Bony lesion 46 - 13 M R
2 Osteoma Bony lesion 44 - 34 M R
3 Chronic inflammation Inflammation 1 + (Pseudomonas aeruginosa) 24 F L
4 Epidermal cyst Epithelial lesion 1 + (Pseudomonas aeruginosa) 63 M R
5 Fibroepithelial polyp Epithelial lesion 1 +(MSSA) 63 F L
6 Intraepidermal pilarepithelioma Epithelial lesion 6 - 51 M R

Abbreviations: MSSA: Methicillin

DISCUSSION

Benign tumors originating from the EAC are uncommon and usually asymptomatic; thus, most of them are found incidentally. But they can sometimes cause aural symptoms such as ear fullness, conductive hearing impairment, otitis externa, otalgia, and tinnitus. Surgical removal is the standard treatment. It has also been suggested that ear symptoms assumed to be due to EAC tumor could be alleviated by tumor excision [4].

In this study, occurrence of EAC tumor was not associated with sex or age; this finding is similar to those of other reports [5]. In previous studies, bony lesions (eg, osteoma, exostoses) were found to be the most common pathologic types of benign EAC tumors [1,3]. However, nevus was the most common form of EAC tumor in this study.

Nevus, one of the most common benign skin tumors, is a sharply-circumscribed overgrowth of cells associated with melanocytic migration and proliferation [6]. It usually has a uniform surface and coloration pattern, round or oval shape, and relatively regular border (Figure 1A,B).

Otoendoscopic findings of each pathologic type. A. Nevus (compound type), B. Nevus (intradermal type), C. Osteoma, D. Fibroepithelial polyp, E. Epidermal cyst, F. Chronic inflammation

Figure 1: Otoendoscopic findings of each pathologic type. A. Nevus (compound type), B. Nevus (intradermal type), C. Osteoma, D. Fibroepithelial polyp, E. Epidermal cyst, F. Chronic inflammation.

Most cases are acquired in childhood and puberty and peak in the fourth decade of life [7]. (In this case series, the average age was 39.6 years in the nevus group.) Histologically, nevi are divided into three subtypes according to the location of clusters of melanocytic cells; junctional nevus in the epidermis, intradermal nevus in the dermis (Figure 2A) and compound nevus in both areas. Flat junctional nevi have darker pigmentation, whereas more elevated compound nevi have a lighter brown to black color (Figure 1A). Intradermal nevi are elevated lesions without pigmentation (Figure 1B). Lim et al. reported that the intradermal type was the most common among EAC nevi; the same tendency was shown in this study [8].

Some have insisted that acquired EAC nevi must be removed in all cases, or if symptoms are evident [9]. After incomplete removal, nevi may reappear as recurrent lesions (pseudomelanoma), clinically and pathologically similar to malignant melanoma in situ regardless of the initial pathology [10]. Early and complete resection should thus be recommended for EAC nevi. In this study, no nevus patients experienced relapse. Nevus is one of the most frequently acquired skin neoplasms in Caucasians. Most Caucasian adults have about 20 nevi but is less common in Black individuals or other persons with highly pigmented skin [11]. Because this review involves only South Korean patients of Asian ethnicity, further study on interracial differences of EAC nevi is recommended. The clinical presentation of osteoma in the EAC is a solitary, slow-growing, and pedunculated mass in the unilateral bony canal [2,12] (Figure 1C). It is known to arise from tympanomastoid and tympanosquamous suture lines after persistent or repetitive exposure of the ears to cold water [13]. Recurrence had occurred in 2 of 7 osteoma patients 45 months after the first excision. The recurrence rate of osteoma is much higher than overall rate for EAC tumors, and the duration of recurrence is also longer than average (16.5 months). Long-term follow-up is therefore recommended for bony lesions in EAC. In this study, one case was diagnosed as a fibro epithelial polyp (Figure 1D) and recurred twice, so the patient underwent surgical excision two times. Fibroepithelial polyp is a benign lesion of mesodermal origin that is most commonly found in the skin and genitourinary tract, but very rarely in the EAC. Their etiology is thought to be an underlying chronic inflammatory process, but remains largely unknown [14,15]. In EAC, fibro epithelial polyp was assumed to be a secondary, reactive change in the skin to an initial inflammatory change or an osteoma [4,6]. Figure 2,

Microscopic findings of each pathologic type. A. Nevus (intradermal), view of melanocyts with brown pigmentation (arrow), (x100) B. Fibroepithelial polyp, solitary, pendunculated growth pattern, benign squamous epithelial lining with moderate acanthosis (white arrow), mild papillomatosis (black arrow) (x40) C. Fibroepithelial polyp, view of fibrotic backgrounds (white arrow) with vessels (black arrow), (x200).

Figure 2: Microscopic findings of each pathologic type. A. Nevus (intradermal), view of melanocyts with brown pigmentation (arrow), (x100) B. Fibroepithelial polyp, solitary, pendunculated growth pattern, benign squamous epithelial lining with moderate acanthosis (white arrow), mild papillomatosis (black arrow) (x40) C. Fibroepithelial polyp, view of fibrotic backgrounds (white arrow) with vessels (black arrow), (x200).

B and C show the histopathologic characteristics of fibro epithelial polyp. It presents a solitary, pendunculated growth pattern and has benign squamous epithelial linings with moderate acanthosis and mild papillomatosis [16]. In our study, the fibroepthelial polyp case had no clinical findings suggesting history of aural polyp or other ear disorders, or mechanical stimulation of the EAC. Tanaka et al. reported the first known case of independent fibroepithelial polyp of the EAC [5]. In epithelial lesions, epidermal cyst presents as a solitary, rounded mass that has an epidermallike wall (Figure 1E). A chronic inflammatory mass in the EAC has an erythematous nodular appearance (Figure 1F). The overall recurrence rate was 11% (6 of 53); incomplete resection of the tumor was thought to be the main cause of relapse. Furthermore, culture of otorrhea identified pathogens in half of patients with recurrence, and the recurrence rate was considerably higher (50%) in cases confirmed to be infected by microorganism. This suggests that infection may increase the risk of recurrence of EAC tumor. Further research should clarify the causal relationship of tumor recurrence and infection in a larger sample size.

This study has some limitations. First, only patients treated surgically were included in this case series; patients who had conservative, medical management or were lost to follow-up were excluded, which could represent a selection bias. Second, the sample size is relatively small. Although the sample size of this analysis is larger than that of any other previous studies of benign EAC benign tumors [1,3], it is still insufficient to clarify the strong correlation between pathologic diagnoses and clinical characteristics. Third, this study was performed only in South Korea and thus does not reflect interracial, regional, and environmental differences. In the future, a larger, multicenter study should be performed to get a more meaningful, powerful result.

CONCLUSION

In conclusion, our results indicated that nevus was the most common pathologic type, and the overall recurrence rate  was 11%. There were no significant differences in age, sex, affected side, recurrence rate, and recurrence duration between pathologic diagnoses. Benign EAC lesions that originate from the epithelium and bony canal should be observed closely in the postoperative period. Treatment of infection is also thought to be important for preventing recurrence.

REFERENCES

1. Spielmann PM, McKean S, White RD, Hussain SS. Surgical management of external auditory canal lesions. J Laryngol Otol. 2013; 127: 246-251.

2. Carbone PN, Nelson BL. External auditory osteoma. Head Neck Pathol. 2012; 6: 244-246.

3. Wiatr M, Skladzien J. Benign tumors of the external and middle ear from data collected at the Otolaryngologyst Department of the Jagiellonian University in Cracow between1992-2001. Przegl Lek. 2007; 64: 1004-1005.

4. Toma AG, Fisher EW. Osteoma of the external auditory meatus presenting as an aural polyp. J Laryngol Otol. 1993; 107: 935-936.

5. Tanaka N, Matsunobu T, Shiotani A. Fibroepithelial polyp of the external auditory canal: a case report and a literature review. Case Rep Otolaryngol. 2013: 818197..

6. Stegmaier Oc, Becker Sw Jr. Incidence of melanocytic nevi in young adults. J Invest Dermatol. 1960; 34: 125-129.

7. Pariser RJ. Benign neoplasms of the skin. Med Clin North Am. 1998; 82: 1285-1307.

8. Lim HJ, Kim YT, Choo OS, Park K, Park HY, Choung YH. Clinical and histological characteristics of melanocytic nevus in external auditory canals and auricles. Eur Arch Otorhinolaryngol. 2013; 270: 3035- 3042.

9. Alves RV, Brandão FH, Aquino JE, Carvalho MR, Giancoli SM, Younes EA, et al. Intradermal melanocytic nevus of the external auditory canal. Braz J Otorhinolaryngol. 2005; 71: 104-106.

10. Sexton M, Sexton CW. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma. Arch Pathol Lab Med. 1991; 115: 122-126.

11. Wolff K, Johnson RA, Saavedra AP. Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology 7th ed. United States: Mac Graw Hill; 2013.

12. Ebelhar AJ, Gadre AK. Osteoma of the external auditory canal. Ear Nose Throat J. 2012; 91: 96-100.

13. Cumming CW, Fredrickson JM, Harker LA, Krause CJ, Schuller DE, editors. Otolaryngology-Head and Neck Surgery. 6th ed. St Louis: Mosby Year Book; 2015; 2200-2210.

14. Schuster D, Sweeney AD, Eisenberg R, Wanna GB. A case of sensorineural hearing loss involving a fibroepithelial polyp of the middle ear. Am J Otolaryngol. 2015; 36: 475-478.

15. Farboud A, Trinidade A, Harris M, Pfleiderer A. Fibroepithelial polyp of the tonsil: case report of a rare, benign tonsillar lesion. J Laryngol Otol. 2010; 124: 111-112.

16. Elder DE, Elenitsas R, Rosenbach M, Murphy G, Rubin A, Xu X, et al. Lever s Histopatholoy of the skin. 11th ed. Philadelphia: Wolters Kluwer. 2014; 1203-1250.

Kim JR, Im H, Chae SW, Song JJ (2017) Clinical Features of Benign Tumors of the External Auditory Canal According to Pathology. Ann Otolaryngol Rhinol 4(3): 1169.

Received : 31 Mar 2017
Accepted : 20 Apr 2017
Published : 21 Apr 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X